Efficient chromatographic reduction of ovalbumin for egg-based influenza virus purification

Vaccine

Volumn 32, Issue 30, 2014, Pages 3721-3724

  Blom, Hans ^a   Åkerblom, Anna ^a   Kon, Theone ^b   Shaker, Sabah ^b   van der Pol, Leo ^b   Lundgren, Mats ^a  

^a GE Healthcare Bio Sciences AB   (Sweden)

^b Institute for Translational Vaccinology   (Netherlands)

Author keywords

Allantoic fluid; Core bead chromatography; Influenza; Ovalbumin; Ultracentrifugation

Indexed keywords

INFLUENZA VACCINE; OVALBUMIN;

ARTICLE; CHROMATOGRAPHY; CORE BEAD CHROMATOGRAPHY; DENSITY GRADIENT CENTRIFUGATION; IMMUNODIFFUSION; INFLUENZA VIRUS; PRIORITY JOURNAL; ULTRACENTRIFUGATION; VACCINE PRODUCTION; ANIMAL; CHEMISTRY; CHICKEN; INFLUENZA VIRUS A H3N2; ISOLATION AND PURIFICATION; OOCYTE; ORTHOMYXOVIRIDAE; PROCEDURES; VIROLOGY; VIRUS CULTURE;

ANIMALS; CHICKENS; CHROMATOGRAPHY; INFLUENZA A VIRUS, H3N2 SUBTYPE; ORTHOMYXOVIRIDAE; OVALBUMIN; OVUM; VIRUS CULTIVATION;

EID: 84922234916     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.04.033     Document Type: Article

References (12)

1. Influenza report 2006 2006, Flying Publisher. B.S. Kamps, C. Hoffmann, W. Preiser (Eds.).
2. Dawood F.S., Jain S., Finelli L., Shaw M.W., Lindstrom S., Garten R.J., et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009, 360(25):2605-2615.
3. Matthews J.T. Egg-based production of influenza vaccine: 30 years of commercial experience. The Bridge 2006, 36:17-24.
4. Bardiya N., Bae J.H. Influenza vaccines: recent advances in production technologies. Appl Microbiol Biotechnol 2005, 67(3):299-305.
5. Wolff M.W., Reichl U. Downstream processing: from egg to cell culture-derived influenza virus particles. Chem Eng Technol 2008, 31(6):846-857.
6. Gruenberg D.A., Shaker M.S. An update on influenza vaccination in patients with egg allergy. Curr Opin Pediatr 2011, 23(5):566-572.
7. McGrath M., Witte O., Pincus T., Weissman I.L. Retrovirus purification: method that conserves envelope glycoprotein and maximizes infectivity. J Virol 1978, 25(3):923-927.
8. Rodrigues T., Carvalho A., Roldao A., Carrondo M.J., Alves P.M., Cruz P.E. Screening anion-exchange chromatographic matrices for isolation of onco-retroviral vectors. J Chromatogr B Analyt Technol Biomed Life Sci 2006, 837(1/2):59-68.
9. Kalbfuss B., Wolff M., Morenweiser R., Reichl U. Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography. Biotechnol Bioeng 2007, 96:932-944.
10. Opitz L., Salaklang J., Büttner H., Reichl U., Wolff M.W. Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses. Vaccine 2007, 25:939-947.
11. Wood J.M., Schild G.C., Newman R.W., Seagroatt V. An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. J Biol Stand 1977, 5:237-247.
12. Huntington J.A., Stein P.E. Structure and properties of ovalbumin. J Chromatogr B Biomed Sci Appl 2001, 756(1/2):189-198.